These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8804365)

  • 1. Vascular endothelial growth factor stimulates protein kinase C-dependent phospholipase D activity in endothelial cells.
    Seymour LW; Shoaibi MA; Martin A; Ahmed A; Elvin P; Kerr DJ; Wakelam MJ
    Lab Invest; 1996 Sep; 75(3):427-37. PubMed ID: 8804365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAP kinases, phosphatidylinositol 3-kinase, and p70 S6 kinase mediate the mitogenic response of human endothelial cells to vascular endothelial growth factor.
    Yu Y; Sato JD
    J Cell Physiol; 1999 Feb; 178(2):235-46. PubMed ID: 10048588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells.
    Rousseau S; Houle F; Landry J; Huot J
    Oncogene; 1997 Oct; 15(18):2169-77. PubMed ID: 9393975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
    Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
    Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells.
    Ahmed A; Dunk C; Kniss D; Wilkes M
    Lab Invest; 1997 Jun; 76(6):779-91. PubMed ID: 9194854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
    Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase.
    Qi JH; Claesson-Welsh L
    Exp Cell Res; 2001 Feb; 263(1):173-82. PubMed ID: 11161716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
    Béliveau R; Gingras D; Kruger EA; Lamy S; Sirois P; Simard B; Sirois MG; Tranqui L; Baffert F; Beaulieu E; Dimitriadou V; Pépin MC; Courjal F; Ricard I; Poyet P; Falardeau P; Figg WD; Dupont E
    Clin Cancer Res; 2002 Apr; 8(4):1242-50. PubMed ID: 11948139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor stimulates a novel calcium-signaling pathway in vascular smooth muscle cells.
    Chandra A; Angle N
    Surgery; 2005 Oct; 138(4):780-7. PubMed ID: 16269309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth.
    Cai W; Rook SL; Jiang ZY; Takahara N; Aiello LP
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eicosapentaenoic acid attenuates vascular endothelial growth factor-induced proliferation via inhibiting Flk-1 receptor expression in bovine carotid artery endothelial cells.
    Yang SP; Morita I; Murota SI
    J Cell Physiol; 1998 Aug; 176(2):342-9. PubMed ID: 9648921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts.
    Takahashi T; Shibuya M
    Oncogene; 1997 May; 14(17):2079-89. PubMed ID: 9160888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF-dependent signaling in retinal microvascular endothelial cells.
    Enaida H; Kabuyama Y; Oshima Y; Sakamoto T; Kato K; Kochi H; Homma Y
    Fukushima J Med Sci; 1999 Dec; 45(2):77-91. PubMed ID: 11039605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF inhibits PDGF-stimulated calcium signaling independent of phospholipase C and protein kinase C.
    Chandra A; Angle N
    J Surg Res; 2006 Apr; 131(2):302-9. PubMed ID: 16054650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vascular endothelial growth factor on cultured endothelial cell monolayer transport properties.
    Chang YS; Munn LL; Hillsley MV; Dull RO; Yuan J; Lakshminarayanan S; Gardner TW; Jain RK; Tarbell JM
    Microvasc Res; 2000 Mar; 59(2):265-77. PubMed ID: 10684732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
    Wood JM
    Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of KDR expression in bovine arterial endothelial cells by thrombin: involvement of nitric oxide.
    Wang J; Morita I; Onodera M; Murota SI
    J Cell Physiol; 2002 Feb; 190(2):238-50. PubMed ID: 11807828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 1-stimulated prostacyclin synthesis in endothelium: lack of phospholipase C, phospholipase D, or protein kinase C involvement in early signal transduction.
    Garcia JG; Stasek JE; Bahler C; Natarajan V
    J Lab Clin Med; 1992 Dec; 120(6):929-40. PubMed ID: 1333514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.